Cambridge Investment Research Advisors’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-34,590
| Closed | -$430K | – | 3185 |
|
|
2022
Q2 | $430K | Sell |
34,590
-965
| -3% | -$12K | ﹤0.01% | 2075 |
|
|
2022
Q1 | $474K | Sell |
35,555
-1,200
| -3% | -$16K | ﹤0.01% | 2149 |
|
|
2021
Q4 | $572K | Sell |
36,755
-2,250
| -6% | -$35K | ﹤0.01% | 1995 |
|
|
2021
Q3 | $875K | Hold |
39,005
| – | – | ﹤0.01% | 1642 |
|
|
2021
Q2 | $888K | Buy |
39,005
+350
| +0.9% | +$7.97K | ﹤0.01% | 1617 |
|
|
2021
Q1 | $796K | Buy |
38,655
+4,165
| +12% | +$85.8K | ﹤0.01% | 1594 |
|
|
2020
Q4 | $953K | Buy |
34,490
+600
| +2% | +$16.6K | 0.01% | 1339 |
|
|
2020
Q3 | $476K | Sell |
33,890
-9,875
| -23% | -$139K | ﹤0.01% | 1636 |
|
|
2020
Q2 | $902K | Buy |
43,765
+19,190
| +78% | +$396K | 0.01% | 1183 |
|
|
2020
Q1 | $186K | Sell |
24,575
-555
| -2% | -$4.2K | ﹤0.01% | 1968 |
|
|
2019
Q4 | $390K | Buy |
25,130
+14,405
| +134% | +$224K | ﹤0.01% | 1742 |
|
|
2019
Q3 | $56K | Buy |
+10,725
| New | +$56K | ﹤0.01% | 2273 |
|